Viewing Study NCT05580861


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2025-12-27 @ 9:20 PM
Study NCT ID: NCT05580861
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2022-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module